Technical Notes for the 2012 HSMR Public Release
The hospital standardized mortality ratio (HSMR) is a ratio of the actual number of in-hospital deaths in a region or hospital to the number that would have been expected based on the types of patients a region or hospital treats.
| Observed Deaths | ||
| HSMR = | ______________ | X 100 |
| Expected Deaths |
Numerator: Observed deaths, or actual number of in-hospital deaths that occurred in a hospital or region.
Denominator: Expected deaths, or number of deaths that would have occurred in a hospital or region had the mortality of these patients been the same as the mortality of similar patients across the country, based on the reference year (2009–2010).
Regional or corporation-level HSMRs are calculated as the sum of observed deaths for all acute care sites divided by the sum of expected deaths for all acute care sites multiplied by 100. Regional and facility HSMR results are based on where patients were treated, not where they lived.
Inclusion criteria
Exclusion criteria
Some types of patients are more likely than others to die in hospital. For example, older patients and those with certain health problems on admission (comorbidities) are at higher risk. Since these risk factors can change over time and vary from place to place, the HSMR calculation takes these differences into account using a statistical technique known as logistic regression.
For each of the HSMR diagnosis groups, the HSMR logistic regression models are fitted with age, sex, length-of-stay (LOS) group, admission category, comorbidity group and transfers as independent variables. The models are based on data from all acute hospitals in Canada. Coefficients derived from the logistic regression models are used to calculate the probability of in-hospital death. The expected number of deaths for a hospital, corporation or region is based on the sum of the probabilities of in-hospital death for eligible discharges from that organization. The 95% confidence interval is calculated using Byar’s approximation.
A ratio equal to 100 suggests that there is no difference between a local mortality rate and the average national experience, given the types of patients cared for. An HSMR greater or less than 100 suggests that a local mortality rate is higher or lower, respectively, than the national experience.
The confidence intervals describe the precision of the HSMR estimate. The upper and lower confidence intervals are estimated to contain the true value of the HSMR 19 times out of 20 (95% confidence interval). A confidence interval that includes 100 suggests that the HSMR is not statistically different from the 2009–2010 baseline of 100. HSMR results whose confidence interval does not include 100 and are therefore statistically different from the 2009–2010 baseline are denoted with a symbol in the report.
While HSMR adjusts for a number of factors affecting the risk of in-hospital mortality, it does not control for everything. Therefore, HSMR results are most useful in tracking trends over time.
Data source
Discharge Abstract Database, Canadian Institute for Health Information.
Hospital Morbidity Database, Canadian Institute for Health Information.
Reference period
The reference year for HSMR calculations is 2009–2010. To allow for comparisons over time, the coefficients derived from the model using the reference year are used to determine expected deaths for all reported years.
Comprehensiveness
Results are only reported for regions and acute care facilities that meet a statistical threshold for public reporting: at least 2,500 qualifying discharges in each of the last three years being reported i.e. 2009–2010, 2010–2011 and 2011–2012
Alexandrescu, R. et al. “Logistic vs Hierarchical Modeling: An Analysis of a Statewide Inpatient Sample.” Journal of American College of Surgeons 213, 3 (2011): pp. 392–401.
Bottle, A., B. Jarman and P. Aylin. “Hospital Standardized Mortality Ratios: Sensitivity Analyses on the Impact of Coding.” Health Services Research 46, 6 Part 1 (2011): pp. 1741–1761.
Bottle, A., B. Jarman and P. Aylin. “Strengths and Weaknesses of Hospital Standardised Mortality Ratios.” BMJ 342 (2011): p. 7116.
Breslow, N. E. and N. E. Day. Statistical Methods in Cancer Research: Volume II—The Design and Analysis of Cohort Studies. Lyon, France: International Agency for Research on Cancer, 1987.
Jarman, B. et al. “Explaining Differences in English Hospital Death Rates Using Routinely Collected Data.”BMJ 318 (1999): pp. 1515–1520, accessed from <http://bmj.bmjjournals.com/cgi/content/full/318/7197/1515>.
Jarman, B., A. Bottle and P. Aylin. “Monitoring Changes in Hospital Standardised Mortality Ratios.” BMJ 330 (2005): p. 329.
Quan, H. et al. “Updating and Validating the Charlson Comorbidity Index and Score for Risk Adjustment in Hospital Discharge Abstracts Using Data From 6 Countries.” American Journal of Epidemiology 173, 6 (2011): pp. 676–682.
Diagnosis Group |
Description |
A04 |
Other bacterial intestinal infections |
A41 |
Sepsis |
C15 |
Malignant neoplasm of oesophagus |
C16 |
Malignant neoplasm of stomach |
C18 |
Malignant neoplasm of colon |
C22 |
Malignant neoplasm of liver and intrahepatic bile ducts |
C25 |
Malignant neoplasm of pancreas |
C34 |
Malignant neoplasm of bronchus and lung |
C50 |
Malignant neoplasm of breast |
C61 |
Malignant neoplasm of prostate |
C67 |
Malignant neoplasm of bladder |
C71 |
Malignant neoplasm of brain |
C78 |
Secondary malignant neoplasm of respiratory and digestive organs |
C79 |
Secondary malignant neoplasm of other sites |
C80 |
Malignant neoplasm without specification of site |
C83 |
Diffuse non-Hodgkin’s lymphoma |
C85 |
Other and unspecified types of non-Hodgkin’s lymphoma |
C90 |
Multiple myeloma and malignant plasma cell neoplasms |
C92 |
Myeloid leukemia |
E11 |
Diabetes mellitus type 2 |
E86 |
Volume depletion |
E87 |
Other disorders of fluid, electrolyte and acid-base balance |
F03 |
Unspecified dementia |
F05 |
Delirium, not induced by alcohol and other psychoactive substances |
G30 |
Alzheimer’s disease |
G93 |
Other disorders of brain |
I21 |
Acute myocardial infarction (AMI) |
I24 |
Other acute ischemic heart diseases |
I25 |
Chronic ischemic heart disease |
I26 |
Pulmonary embolism |
I35 |
Nonrheumatic aortic valve disorders |
I46 |
Cardiac arrest |
I48 |
Atrial fibrillation and flutter |
I50 |
Heart failure |
I60 |
Subarachnoid haemorrhage |
I61 |
Intracerebral haemorrhage |
I62 |
Other nontraumatic intracranial haemorrhage |
I63 |
Cerebral infarction |
I64 |
Stroke, not specified as haemorrhage or infarction |
I70 |
Atherosclerosis |
I71 |
Aortic aneurism and dissection |
J18 |
Pneumonia |
J44 |
Other chronic obstructive pulmonary disease |
J69 |
Pneumonitis due to solids and liquids |
J80 |
Adult respiratory distress syndrome |
J84 |
Other interstitial pulmonary diseases |
J90 |
Pleural effusion, not elsewhere classified |
J96 |
Respiratory failure, not elsewhere classified |
K26 |
Duodenal ulcer |
K55 |
Vascular disorders of intestine |
K56 |
Paralytic ileus and intestinal obstruction without hernia |
K57 |
Diverticular disease of intestine |
K63 |
Other diseases of intestine |
K65 |
Peritonitis |
K70 |
Alcoholic liver disease |
K72 |
Hepatic failure |
K74 |
Fibrosis and cirrhosis of liver |
K85 |
Acute pancreatitis |
K92 |
Other diseases of digestive system |
L03 |
Cellulitis |
N17 |
Acute renal failure |
N18 |
Chronic renal failure |
N39 |
Other disorders of urinary system |
R53 |
Malaise and fatigue |
R57 |
Shock, not elsewhere classified |
R64 |
Cachexia |
S06 |
Intracranial injury |
S32 |
Fracture of lumbar spine and pelvis |
S72 |
Fracture of femur |
T81 |
Complications of procedures, not elsewhere classified |
T82 |
Complications of cardiac and vascular prosthetic devices, implants and grafts |
Z54 |
Convalescence |
Contact us: hsmr@cihi.ca